These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. National Institutes of Health Consensus Development Panel J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
9. National Institutes of Health Consensus Development Conference Statement: cervical cancer, April 1-3, 1996. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst Monogr; 1996; (21):vii-xix. PubMed ID: 9023821 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive look at the early detection of ovarian cancer. O'Rourke J; Mahon SM Clin J Oncol Nurs; 2003; 7(1):41-7. PubMed ID: 12629933 [TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668 [TBL] [Abstract][Full Text] [Related]
12. Advances in the management of epithelial ovarian cancer. Berkenblit A; Cannistra SA J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567 [TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer. The most lethal gynecologic malignancy. Brucks JA Nurs Clin North Am; 1992 Dec; 27(4):835-45. PubMed ID: 1448359 [TBL] [Abstract][Full Text] [Related]
14. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms. Hall KL; Dewar MA; Perchalski J Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066 [TBL] [Abstract][Full Text] [Related]
15. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel. J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II]. Sevelda P; Gitsch E; Dittrich C; Haider F; Czerwenka K; Schemper M; Salzer H Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):179-85. PubMed ID: 3556307 [TBL] [Abstract][Full Text] [Related]
17. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883 [TBL] [Abstract][Full Text] [Related]
18. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990. Venesmaa P Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329 [TBL] [Abstract][Full Text] [Related]
19. Screening and detection of ovarian cancer. Breedlove G; Busenhart C J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515 [TBL] [Abstract][Full Text] [Related]
20. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women. Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]